Stanford researchers deploy 37,000 AI agents as a virtual biotech
The system successfully generated a drug design that was independently confirmed by Merck. The project moves beyond single-agent workflows to a massive, multi-agent architecture for biomedical data science.
Featured · James Zou
1 source
Daily brief
Get tomorrow's AI brief in your inbox
More stories today
- Claude Auto mode pairs with Opus 5 for multi-hour tasks
- Self-taught developer lands Director of AI role
- Humalike adds humanlike NPC behavior to Poland's biggest GTA RP server
- Sierra launches Voice Personas to give agents a brand voice and personality
- Working config shared for MiniMax Turbo LoRA (LightX2V) Ref2V audio fix